Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs

Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 34.97 --0 (-0%)
Previous Close $34.97    52 Week High $34.07 
Open $34.97    52 Week Low $21.84 
Day High $34.97    P/E N/A 
Day Low $34.97    EPS $0.00 
Volume 130       

Regeneron (NASDAQ: REGN) Delayed: 790.74 -5.6 (0.7%)
Previous Close $796.34    52 Week High $592.36 
Open $803.01    52 Week Low $325.35 
Day High $805.68    P/E 207.54 
Day Low $787.32    EPS $3.81 
Volume 653,987       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 41.50 +0.39 (0.95%)
Previous Close $41.11    52 Week High $66.55 
Open $41.26    52 Week Low $37.82 
Day High $41.70    P/E N/A 
Day Low $40.96    EPS $0.00 
Volume 5,989,597